News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Banner del Webinar de Pharmaron
Register for Webinar: Oligonucleotide Drugs: Key ADME & DMPK Insights
Healthcare
Pharmaron is holding a training webinar on June 20 on the importance of oligonucleotide drugs in…
Foto de una célula
Use of biotechnology in advanced therapies and new technologies in the spanish market
Healthcare · Access to innovation · Advanced therapies
Among the most important emerging technologies are the manipulation of the microbiota, CAR-T cell…
Partners - KONEXIO BIOTECH
Foto de un adulto anciano con un libro entre sus piernas y de un niño señalando el libro
Oryzon announces journal publication of final Phase IIa ALICE results with iadademstat in The Lancet Hematology
Healthcare · Access to innovation · Rare diseases · Innovative drugs · Advanced therapies
The Phase IIa study ALICE evaluated the combination of iadademstat plus azacitidine in newly…
Partners - Oryzon Genomics
Foto de la entrega del premio Nueva Empresa de Gipuzkoa 2024 a VIVEbiotech
VIVEbiotech receives the “New Company of Gipuzkoa 2024” award from ADEGI
Corporate
The award recognizes the success of companies less than 10 years old that create wealth and…
Partners - VIVEbiotech
edificio oryzon
Oryzon to provide corporate progress updates at several events in June
Healthcare · Corporate
BIO International Convention 2024. Congreso de la European Hematology Association (EHA) 2024.…
Partners - Oryzon Genomics
Imagen de una estructura de adn
Key Considerations for Cell and Gene Therapy Commercialization in Non-Orphan Indications
Healthcare · Access to innovation · Drug discovery
There are two important challenges for companies aiming to develop CGTs in mainstream indications.
Oryzon_AseBio
Oryzon selected as Associated Partner in the first Important Project of Common European Interest (IPCEI) in the health sector (Med4Cure project)
Healthcare · Access to innovation · Drug discovery · Rare diseases · Innovative drugs · Personalized medicine · Financing
Commission has approved up to €1 billion of State aid by six Member States: Belgium, France,…
Partners - Oryzon Genomics
Foto de una prueba de Thalassemia
BCN HEALTH publishes a study estimating the cost of thalassaemia care across the world
Healthcare · Rare diseases
BCN HEALTH desarrolló un modelo de costes aplicable a nivel mundial para la atención de la…
Partners - BCN Health
Foto de cuatro manos
Atlas Molecular Pharma successfully completes phase one in humans of its treatment for Congenital Erythropoietic Porphyria Erythropoietica Congenita
Healthcare · Access to innovation · Drug discovery · Rare diseases · Innovative drugs · Personalized medicine
The final results of ATL-001, the biotech company's lead candidate, have shown that it is able to…
Partners - Inveready